Les femmes enceintes doivent-elles éviter les isotopes ?
Oui, l'exposition peut nuire au fœtus, il est donc conseillé de l'éviter.
Femmes enceintesRadioprotectionPhosphore-32
#5
Quels comportements augmentent les risques ?
Le tabagisme et l'exposition à d'autres radiations peuvent augmenter les risques.
Comportements à risqueRadiotoxicitéPhosphore-32
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Radio-isotopes du phosphore : Questions médicales les plus fréquentes",
"headline": "Radio-isotopes du phosphore : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Radio-isotopes du phosphore : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-22",
"dateModified": "2026-07-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Radio-isotopes du phosphore"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Radio-isotopes",
"url": "https://questionsmedicales.fr/mesh/D011868",
"about": {
"@type": "MedicalCondition",
"name": "Radio-isotopes",
"code": {
"@type": "MedicalCode",
"code": "D011868",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.496.749"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Radio-isotopes du phosphore",
"alternateName": "Phosphorus Radioisotopes",
"code": {
"@type": "MedicalCode",
"code": "D010761",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Licia Uccelli",
"url": "https://questionsmedicales.fr/author/Licia%20Uccelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy."
}
},
{
"@type": "Person",
"name": "Petra Martini",
"url": "https://questionsmedicales.fr/author/Petra%20Martini",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy."
}
},
{
"@type": "Person",
"name": "Alessandra Boschi",
"url": "https://questionsmedicales.fr/author/Alessandra%20Boschi",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy."
}
},
{
"@type": "Person",
"name": "Sung-Joon Ye",
"url": "https://questionsmedicales.fr/author/Sung-Joon%20Ye",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Bioengineering and Research Institute for Convergence Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Hiromitsu Haba",
"url": "https://questionsmedicales.fr/author/Hiromitsu%20Haba",
"affiliation": {
"@type": "Organization",
"name": "RIKEN Nishina Center for Accelerator-Based Science, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Protect the oceans from Japan's radioisotope dumping.",
"datePublished": "2023-12-18",
"url": "https://questionsmedicales.fr/article/38318213",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ese.2023.100369"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scandium Radioisotopes-Toward New Targets and Imaging Modalities.",
"datePublished": "2023-11-19",
"url": "https://questionsmedicales.fr/article/38005390",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28227668"
}
},
{
"@type": "ScholarlyArticle",
"name": "In-vivo correlations of fluorescent or radioisotope glucose-analogs in imaging cancer metabolism.",
"datePublished": "2024-01-22",
"url": "https://questionsmedicales.fr/article/38247556",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MNM.0000000000001812"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nanoscale dosimetry for a radioisotope-labeled metal nanoparticle using MCNP6.2 and Geant4.",
"datePublished": "2024-09-03",
"url": "https://questionsmedicales.fr/article/39225623",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mp.17371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tuning the Framework of Thioether-Functionalized Polyazamacrocycles: Searching for a Chelator for Theranostic Silver Radioisotopes.",
"datePublished": "2023-09-28",
"url": "https://questionsmedicales.fr/article/37768780",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.inorgchem.3c02456"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Produits chimiques inorganiques",
"item": "https://questionsmedicales.fr/mesh/D007287"
},
{
"@type": "ListItem",
"position": 3,
"name": "Isotopes",
"item": "https://questionsmedicales.fr/mesh/D007554"
},
{
"@type": "ListItem",
"position": 4,
"name": "Radio-isotopes",
"item": "https://questionsmedicales.fr/mesh/D011868"
},
{
"@type": "ListItem",
"position": 5,
"name": "Radio-isotopes du phosphore",
"item": "https://questionsmedicales.fr/mesh/D010761"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Radio-isotopes du phosphore - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Radio-isotopes du phosphore",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Radio-isotopes du phosphore",
"description": "Comment les radio-isotopes du phosphore sont-ils utilisés en imagerie ?\nQuels types de cancers peuvent être diagnostiqués avec ces isotopes ?\nQuelle est la durée de détection des isotopes dans le corps ?\nLes radio-isotopes du phosphore sont-ils sûrs pour le diagnostic ?\nComment se déroule une scintigraphie au phosphore ?",
"url": "https://questionsmedicales.fr/mesh/D010761#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Radio-isotopes du phosphore",
"description": "Quels symptômes peuvent indiquer une exposition aux isotopes ?\nY a-t-il des effets secondaires immédiats ?\nComment reconnaître une réaction allergique aux isotopes ?\nLes isotopes provoquent-ils des douleurs ?\nQuels signes indiquent une surdose d'isotopes ?",
"url": "https://questionsmedicales.fr/mesh/D010761#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Radio-isotopes du phosphore",
"description": "Comment minimiser l'exposition aux isotopes ?\nQuelles précautions prendre après un traitement ?\nLes travailleurs de la santé doivent-ils se protéger ?\nY a-t-il des recommandations alimentaires après traitement ?\nComment surveiller les effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D010761#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Radio-isotopes du phosphore",
"description": "Comment les isotopes du phosphore sont-ils utilisés en thérapie ?\nQuels cancers sont traités avec le phosphore-32 ?\nQuelle est la méthode d'administration des isotopes ?\nQuels sont les résultats attendus du traitement ?\nY a-t-il des alternatives aux traitements par isotopes ?",
"url": "https://questionsmedicales.fr/mesh/D010761#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Radio-isotopes du phosphore",
"description": "Quelles complications peuvent survenir après traitement ?\nComment gérer les effets secondaires graves ?\nLes isotopes peuvent-ils causer des cancers secondaires ?\nQuels sont les signes d'une infection post-traitement ?\nComment prévenir les complications liées aux isotopes ?",
"url": "https://questionsmedicales.fr/mesh/D010761#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Radio-isotopes du phosphore",
"description": "Qui est à risque d'effets indésirables des isotopes ?\nLes enfants sont-ils plus vulnérables ?\nY a-t-il des prédispositions génétiques ?\nLes femmes enceintes doivent-elles éviter les isotopes ?\nQuels comportements augmentent les risques ?",
"url": "https://questionsmedicales.fr/mesh/D010761#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les radio-isotopes du phosphore sont-ils utilisés en imagerie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont injectés dans le corps pour détecter des anomalies osseuses via scintigraphie."
}
},
{
"@type": "Question",
"name": "Quels types de cancers peuvent être diagnostiqués avec ces isotopes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Principalement les cancers osseux et certains cancers des tissus mous."
}
},
{
"@type": "Question",
"name": "Quelle est la durée de détection des isotopes dans le corps ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée dépend de l'isotope, mais généralement quelques jours à quelques semaines."
}
},
{
"@type": "Question",
"name": "Les radio-isotopes du phosphore sont-ils sûrs pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, utilisés en doses contrôlées, ils sont généralement sûrs pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Comment se déroule une scintigraphie au phosphore ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le patient reçoit une injection, puis des images sont prises avec un gamma-caméra."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une exposition aux isotopes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, douleurs osseuses, et symptômes liés à la radiation peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires immédiats ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets comme des nausées ou des réactions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux isotopes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruptions cutanées, démangeaisons ou gonflements peuvent signaler une allergie."
}
},
{
"@type": "Question",
"name": "Les isotopes provoquent-ils des douleurs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des douleurs osseuses, surtout en cas de traitement."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surdose d'isotopes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Signes de radiotoxicité comme vomissements, fatigue extrême ou saignements."
}
},
{
"@type": "Question",
"name": "Comment minimiser l'exposition aux isotopes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter les procédures d'imagerie et suivre les recommandations de radioprotection."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre après un traitement ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact étroit avec les enfants et les femmes enceintes pendant quelques jours."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé doivent-ils se protéger ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils doivent porter des équipements de protection et suivre des protocoles stricts."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires après traitement ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un médecin, mais généralement, une alimentation équilibrée est conseillée."
}
},
{
"@type": "Question",
"name": "Comment surveiller les effets à long terme ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des bilans de santé sont recommandés pour détecter des effets."
}
},
{
"@type": "Question",
"name": "Comment les isotopes du phosphore sont-ils utilisés en thérapie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour traiter certains cancers, notamment par radiothérapie ciblée."
}
},
{
"@type": "Question",
"name": "Quels cancers sont traités avec le phosphore-32 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Principalement les leucémies et les cancers osseux, comme le myélome multiple."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode d'administration des isotopes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement administrés par injection intraveineuse ou intramusculaire."
}
},
{
"@type": "Question",
"name": "Quels sont les résultats attendus du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réduction de la douleur, amélioration de la qualité de vie et contrôle de la maladie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des alternatives aux traitements par isotopes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie et la radiothérapie externe sont des alternatives possibles."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'anémie, des infections ou des problèmes osseux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un médecin pour des traitements symptomatiques et un suivi approprié."
}
},
{
"@type": "Question",
"name": "Les isotopes peuvent-ils causer des cancers secondaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut augmenter le risque de cancers secondaires."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une infection post-traitement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, rougeur, douleur ou écoulement au site d'injection peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux isotopes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les recommandations médicales et signaler tout symptôme inhabituel rapidement."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'effets indésirables des isotopes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients avec des antécédents de radiothérapie ou des maladies préexistantes."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur organisme en développement est plus sensible aux effets des radiations."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions génétiques peuvent augmenter la sensibilité aux radiations."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter les isotopes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition peut nuire au fœtus, il est donc conseillé de l'éviter."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent les risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme et l'exposition à d'autres radiations peuvent augmenter les risques."
}
}
]
}
]
}
Department of Applied Bioengineering and Research Institute for Convergence Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.
Research Institute for Convergence Science, Seoul National University, Seoul, Republic of Korea.
Advanced Institute of Convergence Technology, Seoul National University, Suwon, Republic of Korea.
Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
•Dumping of Fukushima's radioactive wastewater raises marine food web concern.•Tritium seems to be the most problematic compound.•Long-lived radioisotopes Biomagnify up to 50,000 folds in marine fish ...
The concept of theranostics uses radioisotopes of the same or chemically similar elements to label biological ligands in a way that allows the use of diagnostic and therapeutic radiation for a combine...
To investigate the impact of different tracer modifications on the imaging of cancer metabolism, focusing on the comparison of fluorescent glucose-analog tracers (2-NBDG and 2-DG-750) and the radiolab...
We conducted an in-vitro comparative study using four cancer cell lines, each with unique glucose uptake characteristics. The study involved direct comparison of three tracers: 2-NBDG, 2-DG-750 and 18...
The study revealed that each tracer exhibits distinct internalization behaviors correlated with imaging label size and type. 18F-FDG showed the highest uptake efficiency. Fluorescent molecules were fo...
Our findings demonstrate that despite certain impracticalities, nuclear imaging, particularly using radiolabeled biomolecules like 18F-FDG, offers significant potential for accurately capturing biolog...
Metal nanoparticles (MNPs) labeled with radioisotopes (RIs) are utilized as radio-enhancers due to their ability to amplify the radiation dose in their immediate vicinity. A thorough understanding of ...
This study aims to provide insight into the radio-enhancement effects of MNPs by elucidating nanoscale dosimetry surrounding MNPs labeled with Auger-emitting RIs. We particularly focus on distinguishi...
A 50 nm diameter NP of silver (Ag) core and gold (Au) shell (Ag@Au NP) was assumed to emit mono-energetic electrons and photons (3, 5, 10, 20, and 30 keV), or the energy spectrum corresponding to one ...
The radial doses of 10, 20, and 30 keV electrons estimated by both codes were comparable. However, the radial doses of 3 and 5 keV electrons by MCNP6.2 were much larger near the NP surface than those ...
Given the dominant contribution of electrons to radial doses of MNP labeled with Auger-emitting RIs, physical dose enhancement expected by interactions with photons was hindered. Since there are no av...
Silver-111 is an attractive unconventional candidate for targeted cancer therapy as well as for single photon emission computed tomography and can be complemented by silver-103 for positron emission t...
In this work, we demonstrate the training, conversion, and implementation flow of an FPGA-based bin-ratio ensemble spiking neural network applied for radioisotope identification. The combination of te...
The study aimed to assess the microleakage of nanoparticle-based (NPB) cyanoacrylate sealer and epoxy resin-based (ERB) sealer using radioisotope method and confocal laser scanning microscopy (CLSM)....
A total of 100 single-rooted teeth were collected; specimens were accessed, instrumented, and irrigated, and randomly distributed into 4 groups of 25 samples each: Group I: Positive control, group II:...
The amount of radioactivity observed at first in group III and group IV was 194.76 and 599.12 units, respectively, with...
The NPB sealer can become a potential root canal sealer in future endodontics due to superior physiochemical properties attributed to the cyanoacrylate and incorporated nanoparticles....
The study clinically signifies that we can equally use the radioisotopic method along with confocal method while conducting the microleakage studies. In addition, NPB sealer can be an emerging replace...
Contemporary melting glaciers are considered a secondary source of pollutants including radionuclides. Cryoconite - biogenic sediment on the glacier surface - exhibits high concentrations of natural a...
Phosphorus (P) is essential for growing crops, but the supply of high-quality phosphate rock reserves used for fertilizer production is finite while losses of P from the food/waste system cause consid...
Protection against ionizing radiations is important in laboratories with radioactive materials and high energy cyclotron beams. The Cyclotron and Radioisotope Center (CYRIC) located in Tohoku universi...